Advanced Search
Contact | Corporate | Help

Preoperative Dose-dense Doxorubicin and Cyclophosphamide Followed by Paclitaxel With Bevacizumab in Operable Breast Cancer

Sponsors:
  • Dana-Farber Cancer Institute
  • Genentech
  • Massachusetts General Hospital
  • Brigham and Women's Hospital
  • New Hampshire Oncology-Hematology PA
Phases:
  • Phase II
IndicationsAcronym:
  • Breast Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Doxorubicin
  • Drug: Cyclophosphamide
  • Drug: Paclitaxel
  • Drug: Bevacizumab
Enrollment:
100

Additional information about NCT00546156.


SourceSolution © 2008-2012